86 related articles for article (PubMed ID: 3274855)
1. Outcome of kidney transplantation in highly sensitized patients in Scandiatransplant.
Lamm LU; Madsen M; Fjeldborg D
Transplant Proc; 1987 Feb; 19(1 Pt 1):729-30. PubMed ID: 3274855
[No Abstract] [Full Text] [Related]
2. Computer algorithm that predicts both acceptable and unacceptable private and public HLA class I antigens in highly sensitized patients.
Thompson JS; Bryne JE; Hempel HO; Oldfather JW; Green WF; Crowe DO; Sanfilippo F; MacQueen JM; McCalmon RN; Tardiff GN
Transplant Proc; 1993 Feb; 25(1 Pt 1):251-4. PubMed ID: 8438290
[No Abstract] [Full Text] [Related]
3. Modulation of the HLA-A, -B, -DR matching effect by cyclosporin therapy.
Persijn GG; D'Amaro J; de Lange P; Schreuder GM; van Rood JJ
Transplant Proc; 1989 Feb; 21(1 Pt 1):656-8. PubMed ID: 2650212
[No Abstract] [Full Text] [Related]
4. Molecular matching for clinical kidney transplantation.
Takemoto S; Terasaki PI; Maruya E; Park MS
Transplant Proc; 1993 Feb; 25(1 Pt 1):206. PubMed ID: 7679811
[No Abstract] [Full Text] [Related]
5. Is cyclosporine a match for tissue typing centers? Role of the zero HLA-A, B, and DR mismatch effect.
Cicciarelli J; Terasaki PI; Cecka M; Mickey MR
Transplant Proc; 1987 Feb; 19(1 Pt 1):647-9. PubMed ID: 3274831
[No Abstract] [Full Text] [Related]
6. Positive B cell crossmatches in highly sensitized patients--influence of antibody specificity on renal transplant outcome.
Lazda VA; Pollak R; Mozes MF; Jonasson O
Transplant Proc; 1987 Feb; 19(1 Pt 1):782-4. PubMed ID: 3547840
[No Abstract] [Full Text] [Related]
7. A microabsorption assay to determine acceptable HLA-A and B mismatches for highly immunized patients.
van Eijck EL; van der Keur C; Gijbels Y; Bruning JW; van Rood JJ; Claas FH
Transplant Proc; 1989 Feb; 21(1 Pt 1):724-5. PubMed ID: 2650243
[No Abstract] [Full Text] [Related]
8. The predictive value of epitope analysis in highly sensitized patients awaiting renal transplantation.
Laundy GJ; Bradley BA
Transplantation; 1995 Apr; 59(8):1207-13. PubMed ID: 7537397
[TBL] [Abstract][Full Text] [Related]
9. Revisiting HLA matching for kidney transplantation.
Opelz G; Wujciak T; Mytilineos J; Scherer S
Transplant Proc; 1993 Feb; 25(1 Pt 1):173-5. PubMed ID: 8438263
[No Abstract] [Full Text] [Related]
10. The impact of HLA-A,B match of primary renal allografts subsequent to transplant failure.
Sanfilippo F; Goeken N; Niblack G; Scornik J; Vaughn WK
Transplant Proc; 1987 Feb; 19(1 Pt 1):669-71. PubMed ID: 3274835
[No Abstract] [Full Text] [Related]
11. Utility of HLAMatchmaker and single-antigen HLA-antibody detection beads for identification of acceptable mismatches in highly sensitized patients awaiting kidney transplantation.
Goodman RS; Taylor CJ; O'Rourke CM; Lynch A; Bradley JA; Key T
Transplantation; 2006 May; 81(9):1331-6. PubMed ID: 16699463
[TBL] [Abstract][Full Text] [Related]
12. Identification of the antibodies involved in B-cell crossmatch positivity in renal transplantation.
Le Bas-Bernardet S; Hourmant M; Valentin N; Paitier C; Giral-Classe M; Curry S; Follea G; Soulillou JP; Bignon JD
Transplantation; 2003 Feb; 75(4):477-82. PubMed ID: 12605113
[TBL] [Abstract][Full Text] [Related]
13. Selection of cross-match negative HLA-A and/or -B mismatched donors for highly sensitized patients.
Claas FH; Gijbels Y; von Veen A; de Waal LP; D'Amaro J; Persijn GG; van Rood JJ
Transplant Proc; 1989 Feb; 21(1 Pt 1):665-6. PubMed ID: 2650216
[No Abstract] [Full Text] [Related]
14. Recipient sensitization against donor cells in pre- and/or posttransplantation sera is inversely correlated with graft survival.
Sumitran S; Forsberg I; Lindholm A; Lundgren G; Möller E
Transplant Proc; 1987 Feb; 19(1 Pt 2):1566-7. PubMed ID: 3274384
[No Abstract] [Full Text] [Related]
15. Re-exposure to mismatched HLA class I is a significant risk factor for graft loss: multivariable analysis of 259 kidney retransplants.
House AA; Chang PC; Luke PP; Leckie SH; Howson WT; Ball EJ; Tan AK; Rehman F; Muirhead N; Hollomby DJ; McAlister VC; Hodsman AB; Jevnikar AM
Transplantation; 2007 Sep; 84(6):722-8. PubMed ID: 17893605
[TBL] [Abstract][Full Text] [Related]
16. Cadaveric kidneys should be allocated according to the HLA match.
Opelz G; Wujciak T
Transplant Proc; 1995 Feb; 27(1):93-9. PubMed ID: 7879235
[No Abstract] [Full Text] [Related]
17. Renal allograft survival in CSA-treated patients with positive donor-specific B cell crossmatches.
Noreen HJ; van der Hagen E; Bach FH; Najarian JS; Fryd DS
Transplant Proc; 1989 Feb; 21(1 Pt 1):691-2. PubMed ID: 2650224
[No Abstract] [Full Text] [Related]
18. Plasma exchange and immunosuppressive therapy before renal transplantation in highly sensitized patients.
Fauchald P; Leivestad T; Bratlie A; Jakobsen A; Flatmark A
Transplant Proc; 1987 Feb; 19(1 Pt 1):727-8. PubMed ID: 3274854
[No Abstract] [Full Text] [Related]
19. Clinical relevance of a positive B-cell crossmatch on renal transplantation: a multi-transplant center evaluation.
Bryan CF; Aeder MI; Helling TS; Luger AM; Nelson PW; Pierce GE
Transplant Proc; 1993 Feb; 25(1 Pt 1):247-50. PubMed ID: 8438288
[No Abstract] [Full Text] [Related]
20. HLA matching and short/long-term outcome of cadaveric renal allografts: large single-centre data confirm the multicentre analyses.
Petersen P; Schneeberger H; Schleibner S; Illner WD; Hofmann GO; Scholz S; Albert ED; Land W
Transplant Proc; 1995 Feb; 27(1):651-2. PubMed ID: 7879131
[No Abstract] [Full Text] [Related]
[Next] [New Search]
